Filing Flows › Comparisons › PACB vs ALMR
Pacific Biosciences of California vs Alamar Biosciences: PACB and ALMR compared
Pacific Biosciences of California is the larger company: $40.6M of revenue in its latest quarter (Q3 2026) against $33.5M for Alamar Biosciences (Q3 2026). Alamar Biosciences is growing faster (+68% against +6% a year earlier). Alamar Biosciences is more profitable, with an operating margin of -45.1% against -91.2%.
Where the money goes: PACB and ALMR
Pacific Biosciences of California (PACB) · Q3 2026
Pacific Biosciences of California, Q3 2026: revenue $40.6M (+6% year over year), operating margin -91.2%, net loss $37.8M, operating cash flow −$37.6M. The chart follows the revenue to costs, profit and cash.
Alamar Biosciences (ALMR) · Q3 2026
Alamar Biosciences, Q3 2026: revenue $33.5M (+68% year over year), operating margin -45.1%, net loss $13.3M, operating cash flow −$14.7M. The chart follows the revenue to costs, profit and cash.
| Pacific Biosciences of California (PACB) | Alamar Biosciences (ALMR) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $40.6M | $33.5M |
| Revenue growth, Y/Y | +6% | +68% |
| Operating margin | -91.2% | -45.1% |
| Net earnings | −$37.8M | −$13.3M |
| Net margin | -93.3% | -39.8% |
| Operating cash flow | −$37.6M | −$14.7M |
Where the revenue comes from
Pacific Biosciences of California
- Product revenue: $34.0M (84%)
- Service and other revenue: $6.6M (16%)
Alamar Biosciences
- Product: $26.3M (78%)
- Service Other: $7.2M (22%)
Questions
Which is bigger, Pacific Biosciences of California or Alamar Biosciences?
Pacific Biosciences of California is the larger company: $40.6M of revenue in its latest quarter (Q3 2026) against $33.5M for Alamar Biosciences (Q3 2026).
Is Pacific Biosciences of California or Alamar Biosciences growing faster?
Alamar Biosciences is growing faster (+68% against +6% a year earlier).
Which is more profitable, Pacific Biosciences of California or Alamar Biosciences?
Alamar Biosciences is more profitable, with an operating margin of -45.1% against -91.2%.
More: Pacific Biosciences of California earnings · how Pacific Biosciences of California makes money · Alamar Biosciences earnings · how Alamar Biosciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.